KLF6 and Familial prostate cancer: Besides, the treatment with lovastatin, a hypercholesterolemia drug, was also able to induce the expression of KLF6 in cisplatin-resistant HCP4 cervical cancer and PCDP5 prostate cancer cells, leading to cell cycle arrest and apoptosis [145].